Veea Inc. Enters Amendment, Cancels Warrants with White Lion

What Happened

• Veea Inc. announced on its Form 8‑K that on August 10, 2026 it entered into an Amendment, Waiver and Warrant Cancellation Agreement with White Lion Capital LLC. The agreement amends prior financing arrangements between the parties that began under a Note Purchase Agreement dated January 14, 2026, under which Veea issued unsecured convertible promissory notes and common stock warrants to White Lion in multiple closings. The filing also includes as exhibits a Convertible Promissory Note dated July 10, 2026 and the August 10, 2026 Amendment/Waiver/Warrant Cancellation Agreement.

Key Details

• Note Purchase Agreement originally provided for issuance of up to $2,500,000 in unsecured Convertible Notes to White Lion.
• Three earlier issuances (per prior 8‑K disclosures):
  • First Closing (Jan 14, 2026): First Note face amount $555,556; Warrant for 990,099 shares at $0.505 exercise price; net cash proceeds $475,000.
  • Second Closing (Apr 16, 2026): Second Note face amount $555,556; Warrant for 734,214 shares (based on $0.6806 closing price); net cash proceeds $500,000.
  • Third Closing (May 18, 2026): Third Note face amount $555,556; Warrant for 888,509 shares (based on $0.563 closing price); net cash proceeds $500,000.
• Aggregate face amount of the three issued notes = $1,666,668; total net cash received from those closings = $1,475,000.
• Exhibits filed: 4.1 Convertible Promissory Note (dated July 10, 2026) and 10.1 Amendment, Waiver and Warrant Cancellation Agreement (dated Aug 10, 2026).

Why It Matters

• The August 10 agreement addresses key terms of Veea’s financing with White Lion, including a cancellation of warrants — a change that can reduce potential future equity dilution from those warrants. It also reflects ongoing adjustments to the company’s convertible debt financing.
• For investors, this affects Veea’s capital structure (debt levels and potential equity dilution). The 8‑K does not detail all amendment terms in the narrative, so investors should review the filed exhibits (especially the Amendment and the July 10, 2026 note) for specifics on what provisions were waived or changed and any impact on conversion, maturity, or repayment terms.